CRIS

Curis Inc

$0.52 -7.65%

Recent alerts on CRIS

All signals →

News Curis (CRIS) Q2 Loss Narrows 66%

News Curis anticipates TakeAim CLL initial 5-patient dosing by mid-2026 while projecting cash runway into second half of '27

News Curis targets full enrollment in PCNSL registrational study within 12–18 months while advancing CLL proof-of-concept

SEC filing CRIS Posts $0.00 EPS, $0.00 Revenue, Announces $80.8M PIPE Financing, TakeAim Lymphoma ORR 100% BTKi-Naïve, 37% BTKi-Experienced, Orphan Drug Designation, Phase 2 CLL Study Initiated

SEC filing CRIS Announces $50M Share Increase, 2026 Incentive Plan Approved, 6.87M For 0.84M Against

SEC filing CRIS Regains Compliance with Nasdaq MVLS Rule, Subject to One-Year Discretionary Panel Monitor

News Curis Announces Closing of Private Placement Totaling up to $80.8 Million in Gross Proceeds

News CU INC. ELIGIBLE DIVIDENDS

News Hungary Holds Key Rate as Investors Eye New Inflation Projection

Scanner Unusual volume (z=3.4)

News Premier Equipment Company acquires Winston Tractor Company

Get push alerts for CRIS

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS